REGN
Regeneron Pharmaceuticals Inc
NASDAQ: REGN · HEALTHCARE · BIOTECHNOLOGY
$707.06
+3.02% today
Updated 2026-04-30
Market cap
$74.13B
P/E ratio
17.27
P/S ratio
4.97x
EPS (TTM)
$40.94
Dividend yield
0.52%
52W range
$475 – $820
Volume
0.7M
Regeneron Pharmaceuticals Inc (REGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $585.09M | $936.26M | $670.04M | $741.20M | $1.09B | $1.32B | $2.08B | $2.95B | $3.87B | $5.61B | $6.97B | $8.76B | $11.73B | $14.81B | $17.16B | $25.43B | $29.21B | $33.08B | $37.76B | $40.56B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $469.98M | $797.83M | $521.44M | $425.51M | $720.05M | $913.59M | $1.62B | $2.25B | $2.51B | $3.38B | $3.91B | $5.60B | $7.96B | $7.69B | $12.75B | $14.01B | $15.88B | $19.48B | $18.66B | $27.81B |
| Total liabilities | $368.47M | $475.99M | $251.19M | $344.44M | $561.62M | $837.85M | $835.11M | $998.94M | $1.33B | $1.95B | $2.52B | $2.62B | $2.98B | $3.72B | $6.14B | $6.67B | $6.55B | $7.11B | $8.41B | $9.30B |
| Current liabilities | $45.01M | $283.66M | $83.67M | $93.58M | $109.06M | $148.27M | $163.55M | $298.83M | $620.14M | $760.62M | $1.24B | $967.42M | $1.35B | $2.10B | $2.81B | $3.93B | $3.14B | $3.42B | $3.94B | $5.83B |
| Long-term debt | $200.00M | — | — | $109.02M | $159.35M | $275.02M | $296.52M | $320.31M | $146.77M | $362.92M | $351.57M | $703.45M | — | — | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-687.62M | $-793.22M | $-875.93M | $-941.10M | $-1.05B | $-1.27B | $-517.05M | $-92.69M | $255.38M | $852.70M | $1.75B | $2.95B | $5.25B | $7.38B | $10.89B | $18.97B | $23.31B | $27.26B | $31.67B | $35.80B |
| Accounts receivable | $7.49M | $18.32M | $35.21M | $65.57M | $81.92M | $103.03M | $693.12M | $954.97M | $1.02B | $1.47B | $1.61B | $1.97B | $2.24B | $2.79B | $4.11B | $6.04B | $5.33B | $5.67B | $6.21B | $5.74B |
| Inventory | — | — | — | — | $-15.14M | $13.56M | $28.64M | $70.35M | $128.86M | $238.58M | $399.36M | $726.14M | $1.15B | $1.42B | $1.92B | $1.95B | $2.40B | $2.58B | $3.09B | $3.20B |
| Goodwill | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | $-6.84B | — | $-1.00 | — | — |